Compare IH & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IH | ANIK |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 134.8M |
| IPO Year | 2020 | 1993 |
| Metric | IH | ANIK |
|---|---|---|
| Price | $2.05 | $10.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 17.9K | ★ 154.1K |
| Earning Date | 03-24-2026 | 02-26-2026 |
| Dividend Yield | ★ 4.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $119,261,855.00 | $112,806,000.00 |
| Revenue This Year | $39.02 | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $1.76 | $7.87 |
| 52 Week High | $3.60 | $18.35 |
| Indicator | IH | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 57.64 |
| Support Level | $1.95 | $9.97 |
| Resistance Level | $2.24 | $10.62 |
| Average True Range (ATR) | 0.06 | 0.38 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 59.14 | 59.79 |
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.